oxazoles has been researched along with African Lymphoma in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brors, B; Huber, W; Hüllein, J; Kurilov, R; Lee, KS; Lukas, M; Oleś, M; Sellner, L; Tomska, K; Wagner, L; Walther, T; Zenz, T | 1 |
| Craig, RW; Kasof, G; Nifoussi, SK; Ornstein, DL; Ratcliffe, NR; Strack, S | 1 |
| Daniels, I; Haynes, AP; Turzanski, J | 1 |
| Chatfield, K; Eastman, A | 1 |
| Lavin, MF; Song, Q | 1 |
| Craig, RW; Domina, AM; Smith, JH | 1 |
6 other study(ies) available for oxazoles and African Lymphoma
| Article | Year |
|---|---|
Drug-based perturbation screen uncovers synergistic drug combinations in Burkitt lymphoma.
Topics: Acetanilides; Agammaglobulinaemia Tyrosine Kinase; Antineoplastic Agents; Bridged Bicyclo Compounds, Heterocyclic; Burkitt Lymphoma; Cell Line, Tumor; Drug Combinations; Drug Synergism; Heterocyclic Compounds, 3-Ring; Humans; Oxazoles; Phosphoinositide-3 Kinase Inhibitors; Proto-Oncogene Proteins c-bcl-2; Sulfonamides; Thiazoles | 2018 |
Inhibition of protein phosphatase 2A (PP2A) prevents Mcl-1 protein dephosphorylation at the Thr-163/Ser-159 phosphodegron, dramatically reducing expression in Mcl-1-amplified lymphoma cells.
Topics: Binding Sites; Burkitt Lymphoma; Cell Line, Tumor; Drug Resistance, Neoplasm; Enzyme Inhibitors; Gene Expression; Gene Knockdown Techniques; Humans; MAP Kinase Signaling System; Marine Toxins; Myeloid Cell Leukemia Sequence 1 Protein; Okadaic Acid; Oxazoles; Phosphorylation; Protein Phosphatase 2; Proteolysis; Serine; Tetradecanoylphorbol Acetate; Threonine | 2014 |
A requirement for calcium in the caspase-independent killing of Burkitt lymphoma cell lines by Rituximab.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antineoplastic Agents; B-Lymphocytes; Burkitt Lymphoma; Calcium; Calcium Channel Blockers; Caspases; Cell Death; Cell Line; Cell Membrane; Dantrolene; Endoplasmic Reticulum; Flow Cytometry; Humans; Imidazoles; Inositol 1,4,5-Trisphosphate Receptors; Macrocyclic Compounds; Oxazoles; Rituximab; Ryanodine | 2008 |
Inhibitors of protein phosphatases 1 and 2A differentially prevent intrinsic and extrinsic apoptosis pathways.
Topics: Apoptosis; Burkitt Lymphoma; Cell Line, Tumor; Enzyme Inhibitors; Humans; Jurkat Cells; Marine Toxins; Okadaic Acid; Oxazoles; Phosphoprotein Phosphatases; Pyrans; Signal Transduction; Spiro Compounds; U937 Cells | 2004 |
Calyculin A, a potent inhibitor of phosphatases-1 and -2A, prevents apoptosis.
Topics: Apoptosis; Burkitt Lymphoma; DNA Damage; DNA, Neoplasm; Dose-Response Relationship, Drug; Gamma Rays; Humans; Marine Toxins; Oxazoles; Phosphoprotein Phosphatases; Tumor Cells, Cultured | 1993 |
Myeloid cell leukemia 1 is phosphorylated through two distinct pathways, one associated with extracellular signal-regulated kinase activation and the other with G2/M accumulation or protein phosphatase 1/2A inhibition.
Topics: Burkitt Lymphoma; Cell Cycle; Cell Survival; Enzyme Activation; Enzyme Inhibitors; G2 Phase; Humans; Marine Toxins; Microtubules; Mitogen-Activated Protein Kinases; Mitosis; Myeloid Cell Leukemia Sequence 1 Protein; Neoplasm Proteins; Nocodazole; Okadaic Acid; Oxazoles; Paclitaxel; Phosphorylation; Protein Kinase C; Protein Phosphatase 1; Protein Tyrosine Phosphatases; Proto-Oncogene Proteins c-bcl-2; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured; Vinblastine | 2000 |